Background: Coronary heart disease
(CHD) remains the major cause of mortality and morbidity in the entire world
population despite therapeutic advances that control many risk factors. Lipid
profile is regarded as an important factor in the development of coronary heart
disease. There have been numerous studies confirming the association of
hyperlipidemias with coronary heart disease in most of the Western as well as
Asian countries of the world. But we have
very little data on the relation between CHD and lipid profile.Aim of the Study: The aim of this study was to assess abnormal
lipid levels and their association with coronary heart disease.Methods: This comparative observational study was conducted at the Department of Cardiology in M. Abdur Rahim Medical
College, Dinajpur, Bangladesh from
January 2019 to December 2019. Properly written consent was taken from all the
participants before starting the main part of the investigation. Obeying
inclusion and exclusion criteria of the study, a total of 131 participants were
finalized as the study population. Among them, the Case Group was formed with
90 patients who had CHD, and with 41 healthy
people, the Control Group wasformed.
All necessary data were collected, analyzed, and disseminated by several
programs of MS-Office and SPSS version 23. Result: The study was
conducted with 90 case group participants and 41 control group participants.
Among the case group, 78% were male and 22% were female. Among the male case
group participants, 44.29% were from 51-60
years of age, 35.71% were from 41
References
[1]
D’Agostino, R.B., Russell, M.W., Huse, D.M., Ellison, R.C., Silbershatz, H., Wilson, P.W. and Hartz, S.C. (2000) Primary and Subsequent Coronary Risk Appraisal: New Results from the Framingham Study. American Heart Journal, 139, 272-281.
[2]
Natarajan, P., Ray, K.K. and Cannon, C.P. (2010) High-Density Lipoprotein and Coronary Heart Disease: Current and Future Therapies. Journal of the American College of Cardiology, 55, 1283-1299.
[3]
Adak, M. and Shivapuri, J.N. (2010) Serum Lipid and Lipoprotein Profile Abnormality in Predicting the Risk of Coronary Artery Disease in Non-Diabetic Patients Attending NMCTH, Birgunj. Nepal Medical College Journal, 12, 158-164.
[4]
Bonow, R.O., Carabello, B.A., Chatterjee, K., De Leon, A.C., Faxon, D.P., Freed, M.D., Gaasch, W.H., Lytle, B.W., Nishimura, R.A., O’Gara, P.T., O’Rourke, R.A., et al. (2006) ACC/AHA 2006 Guidelines for the Management of Patients with Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients with Valvular Heart Disease): Developed in Collaboration with the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Journal of the American College of Cardiology, 114, e84-e231.
[5]
Voight, B.F., Peloso, G.M., Orho-Melander, M., Frikke-Schmidt, R., Barbalic, M., Jensen, M.K., et al. (2012) Plasma HDL Cholesterol and Risk of Myocardial Infarction: A Mendelian Randomisation Study. The Lancet, 380, 572-580. https://doi.org/10.1016/S0140-6736(12)60312-2
[6]
Ridker, P.M., Pare, G., Parker, A.N., Zee, R.Y., Miletich, J.P. and Chasman, D.I. (2009) Polymorphism in the CETP Gene Region, HDL Cholesterol, and Risk of Future Myocardial Infarction: Genomewide Analysis among 18 245 Initially Healthy Women from the Women’s Genome Health Study. Circulation: Cardiovascular Genetics, 2, 26-33.
[7]
Brown, B.G., Zhao, X.Q., Chait, A., Fisher, L.D., Cheung, M.C., Morse, J.S., Dowdy, A.A., Marino, E.K., Bolson, E.L., Alaupovic, P. and Frohlich, J. (2001) Simvastatin and Niacin, Antioxidant Vitamins, or the Combination for the Prevention of Coronary Disease. New England Journal of Medicine, 345, 1583-1592. https://doi.org/10.1056/NEJMoa011090
[8]
Maxfield, F.R. and Tabas, I. (2005) Role of Cholesterol and Lipid Organization in Disease. Nature, 438, 612-621. https://doi.org/10.1038/nature04399
[9]
Underwood, J.C. and Cross, S.S. (2009) General and Systematic Pathology E-Book. Elsevier Health Sciences.
[10]
Holick, M.F. (2007) Vitamin D Deficiency. New England Journal of Medicine, 357, 266-281. https://doi.org/10.1056/NEJMra070553
[11]
Akanda, M.A., Ali, Z., Choudhury, K.N., Sayami, L.A., Huda, R.M., Hossain, S., Mohsin, M. and Ali, M.A. (2016) Study of Lipid Profile in Adult Population of Bangladesh. Cardiovascular Journal, 8, 128-134.
[12]
Choudhury, K.N., Mainuddin, A.K., Wahiduzzaman, M. and Islam, S.M. (2014) Serum Lipid Profile and Its Association with Hypertension in Bangladesh. Vascular Health and Risk Management, 10, 327-332.
[13]
Kumar, V., Abbas, A. and Aster, J. (2014) Robbins & Cotran Pathologic Basis of Disease. 9th Edition, Elsevier, Singapore.
[14]
Špinar, J. (2012) Hypertension and Ischemic Heart Disease. Cor et Vasa, 54, e433- e438. https://doi.org/10.1016/j.crvasa.2012.11.002
[15]
Paratz, E., Palmer, S. and Mariani, J. (2015) The Cardiac Complications of Obesity. Medicine Today, 16, 211-232.
[16]
Sarwar, N., Danesh, J., Eiriksdottir, G., Sigurdsson, G., Wareham, N., Bingham, S., Boekholdt, S.M., Khaw, K.T. and Gudnason, V. (2006) Triglycerides and the Risk of Coronary Heart Disease: 10,158 Incident Cases among 262,525 Participants in 29 Western Prospective Studies. Circulation, 115, 450-458. https://doi.org/10.1161/CIRCULATIONAHA.106.637793
[17]
Campos, W.D., Stabelini Neto, A., Bozza, R., Ulbrich, A.Z., Bertin, R.L., Mascarenhas, L.P., Silva, S.G. and Sasaki, J.E. (2010) Physical Activity, Lipid Consumption and Risk Factors for Atherosclerosis in Adolescents. Arquivos Brasileiros de Cardiologia, 94, 601-607. https://doi.org/10.1590/S0066-782X2010005000033
[18]
Ahmed, S.M., Clasen, M.E. and Donnelly, J.F. (1998) Management of Dyslipidemia in Adults. American Family Physician, 57, 2192-2208.
[19]
Assessment, R.E. (2009) Major Lipids, Apolipoproteins, and Risk of Vascular Disease. JAMA, 302, 1993-2000. https://doi.org/10.1001/jama.2009.1619
[20]
Werner, M., Gabrielson, D.G. and Eastman, J. (1981) Ultramicro Determination of Serum Triglycerides by Bioluminescent Assay. Clinical Chemistry, 27, 268-271. https://doi.org/10.1093/clinchem/27.2.268
[21]
Alarabawy, R.A., El Ahwal, H.M., Elwagih, M.M., Ismail, A. and Khattab, M.A. (2016) Use of Multi-Detector CT Angiography in Identification and Classification of Aortoiliac Diseases; Clinical and Surgical Application. The Egyptian Journal of Radiology and Nuclear Medicine, 47, 169-178. https://doi.org/10.1016/j.ejrnm.2015.09.005
[22]
Bui, A.L., Horwich, T.B., and Fonarow, G.C. (2011) Epidemiology and Risk Profile of Heart Failure. Nature Reviews Cardiology, 8, 30-41. https://doi.org/10.1038/nrcardio.2010.165
[23]
Fuster, V., Kelly, B.B., Institute of Medicine (US) and Committee on Preventing the Global Epidemic of Cardiovascular Disease: Meeting the Challenges in Developing Countries (2010) Promoting Cardiovascular Health in the Developing World: A Critical Challenge to Achieve Global Health. National Academies Press, Washington DC.
[24]
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J. and Lisheng, L. (2004) Effect of Potentially Modifiable Risk Factors Associated with Myocardial Infarction in 52 Countries (the INTER- HEART Study): Case-Control Study. The Lancet, 364, 937-952. https://doi.org/10.1016/S0140-6736(04)17018-9
[25]
Wilson, P.W., Cupples, L.A. and Kannel, W.B. (1991) Is Hyperglycemia Associated with Cardiovascular Disease? The Framingham Study. American Heart Journal, 121, 586-590. https://doi.org/10.1016/0002-8703(91)90729-2
[26]
Castelli, W.P., Anderson, K., Wilson, P.W. and Levy, D. (1992) Lipids and Risk of Coronary Heart Disease: The Framingham Study. Annals of Epidemiology, 2, 23-28. https://doi.org/10.1016/1047-2797(92)90033-M
[27]
Gotto, A.M. (1991) Cholesterol Intake and Serum Cholesterol Level. New England Journal of Medicine, 324, 912-913.
[28]
Panagiotakos, D.B. and Toutouzas, P.K. (2003) Importance of LDL/HDL Cholesterol Ratio as a Predictor for Coronary Heart Disease Events in Patients with Heterozygous Familial Hypercholesterolaemia: A 15-Year Follow-Up (1987-2002). Current Medical Research and Opinion, 19, 89-94. https://doi.org/10.1185/0300799039117034
